Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Genosis
AddedFeb 19, 2024
UpdatedJun 18, 2026
Genosis

Genosis

Closed

Genosis Inc.: Innovating reproductive disorder diagnosis with proprietary in vitro diagnostic tests.

HQ
Boston, MA, US
Founded
1998
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize reproductive health, Genosis Inc. focuses on developing innovative medical devices for diagnosing reproductive disorders. The company's core vision is to provide accessible and accurate diagnostic solutions to individuals facing infertility challenges. Genosis offers over-the-counter in vitro diagnostic tests designed to screen both male and female infertility, making advanced reproductive health diagnostics more accessible to the general public.

Genosis has garnered attention from notable investors and healthcare professionals who recognize the potential impact of its proprietary technology. The company has achieved significant milestones in product development and market penetration, establishing itself as a key player in the reproductive health diagnostics market. By providing reliable and user-friendly diagnostic tools, Genosis has significantly contributed to advancing reproductive health awareness and treatment options worldwide.

Genosis - Similar Companies

INVO Fertility logo

INVO Fertility

invobioscience.com

Iverson Genetic Diagnostics logo

Iverson Genetic Diagnostics

Microgenesis logo

Microgenesis

microgenesis.net

Gema Diagnostics logo

Gema Diagnostics

gemadx.com

SenGenix logo

SenGenix

sengenix.com

Genassist logo

Genassist

Empowered Diagnostics logo

Empowered Diagnostics

Genendeavor logo

Genendeavor

genendeavor.com

Incept BioSystems logo

Incept BioSystems

Genesis Medtech logo

Genesis Medtech

Geneicd logo

Geneicd

Ovagene Oncology logo

Ovagene Oncology

Biomirror Diagnostics logo

Biomirror Diagnostics

Inform Genomics logo

Inform Genomics

informgenomics.com

Sandstone Diagnostics logo

Sandstone Diagnostics

Genosis - Quick Facts

Who are Genosis' competitors?

Companies similar to Genosis include INVO Fertility, Iverson Genetic Diagnostics, Microgenesis and Gema Diagnostics.

When was Genosis founded?

Genosis was founded in 1998.

Where is Genosis' headquarters located?

Genosis' headquarters is located in Boston, MA, US.

When was Genosis' last funding round?

Genosis' most recent funding round was for $400k (USD) in May 2002.

How much has Genosis raised to-date?

As of May 1, 2002, Genosis has raised a total of $400k (USD).

Genosis - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Diagnostics
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified